Why a long time when there is efficacy already seen early in Ph1 so they are on track to advance the clinical trial to Ph2 next year???? BP don't care about the O/S, they paid what they think the assets are worth for share holders to vote YES and why I also keep saying they don't care about the management.
IMU Price at posting:
4.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)